TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Liabilities | ₹155 Cr | ₹88 Cr | ₹62 Cr | ₹13 Cr |
What is the latest Total Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹88 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹13 Cr |
How is Total Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹155 Cr | 77.20 | |
| Mar2024 | ₹88 Cr | 40.45 | |
| Mar2023 | ₹62 Cr | 385.49 | |
| Mar2022 | ₹13 Cr | - | |
Compare Total Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹291.9 Cr | -0.2% | -4.2% | -15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -0.2% |
-4.2% |
-15% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses